What’s New in MS Research – September 2022

If there’s one theme that emerges from the study findings that follow, it’s how much people with multiple sclerosis (MS) can do to enhance their health and wellbeing. We know that can be a challenging task, as many aspects of the disease and its course remain beyond a person’s control. Nonetheless, the research summarized here provides abundant reason for encouragement.

Read News Article

What’s New in MS Research – July 2022

Hope filled the halls of the Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) during the first week of June, when MS clinicians, researchers, and advocates from across the country and abroad convened to exchange the latest findings in MS research.

Read News Article

What’s New in MS Research – May 2022

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Two studies highlight the beneficial role of diet in managing MS Danish study identifies how gender affects disease course in relapsing MS Can intravaginal estrogen help improve …

Read News Article

What’s New in MS Research – March 2022

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Cut dietary fat to cut daily fatigue, according to a new study Assessing the impact of obesity and depression on people with MS Evidence of neuroprotective effects from stem cel …

Read News Article

What’s New in MS Research – January 2022

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Assessing the impact of disease-modifying therapies on COVID-19 vaccine response Shining a light on fatigue in MS Advances in new imaging technique detect metabolic changes in b …

Read News Article

What’s New in MS Research – November 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article More evidence on the benefits of starting DMTs sooner rather than later Assessing the impact of Ocrevus® on patients with early-stage relapsing-remitting MS Investigational agen …

Read News Article

What’s New in MS Research – September 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Encouraging results from Phase II study of tolebrutinib FDA authorizes stem cell trial focused on people with mild-to-moderate MS Long-term study shows sustained efficacy, consi …

Read News Article

What’s New in MS Research – July 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Good cause to watch for anxiety and depression in the first year after MS diagnosis The case for “starting strong” with an initial disease-modifying therapy Positive results for …

Read News Article

What’s New in MS Research – May 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article Do you and your neurologist attach the same importance to various DMT benefits and risks? Characteristics and clinical outcomes of underserved minority patients with multiple sc …

Read News Article

What’s New in MS Research: March 2021

The first quarter of 2021 has been marked by welcome news on the medical front, and those hopeful developments aren’t limited to the increasing number of COVID-19 vaccinations being given across the country. Significant strides in treating and understanding MS also have been made in these early months of the year, as detailed in this edition of “What’s New in MS Research.”

Read News Article